INVESTIGATION OF VITAMIN D LEVELS IN PATIENTS WITH INACTIVE HEPATITIS B VIRUS CARRIER
dc.authorid | Dokuyucu, Recep/0000-0001-6837-3477 | |
dc.contributor.author | Motor, Sedat | |
dc.contributor.author | Koksaldi-Motor, Vicdan | |
dc.contributor.author | Dokuyucu, Recep | |
dc.contributor.author | Ustun, Ihsan | |
dc.contributor.author | Evirgen, Omer | |
dc.contributor.author | Yilmaz, Nigar | |
dc.contributor.author | Onlen, Yusuf | |
dc.date.accessioned | 2024-09-18T20:26:40Z | |
dc.date.available | 2024-09-18T20:26:40Z | |
dc.date.issued | 2014 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Objective: The purpose of the present study was to investigate vitamin D levels in inactive hepatitis B virus carriers. Materials and methods: A total of 81 patients with inactive hepatitis B virus carrier state were enrolled at the study. Serum calcium (Ca++), phosphorus (PO4), total protein, albumin, parathormone (PTH) and 25-hydroxy vitamin D (25OHD) were determined. Serum vitamin D concentration was classified as lacking when it was less than 50 nmolll (20 ng/ml), insufficient when it was 52.5-72.5 nmol/l (21-29 ng/ml), and sufficient when it was more than 75 nmol/l (30-100 ng/ml). Results: The mean 25OHD level was found to be 131.7 +/- 50.0 nmol/l. Deficiency and insufficiency was seen in one (1.2 %) and nine (11.1 %) inactive hepatitis B virus carriers, respectively. All the patients have normal serum PTH and albumin levels. Total Ca++ and PO4 were low in ten and eight patients, respectively (p<0.05). Conclusion: Vitamin D may cause the stimulation of antiviral immune response and a preventive effect on necroinflammation and liver fibrosis. Therefore, it may affect course of HBV infection. The new studies with larger sample are needed to research the role of vitamin D in the course of chronic HBV infection, liver failure, cirrhosis, and hepatocellular carcinoma. | en_US |
dc.identifier.endpage | 796 | en_US |
dc.identifier.issn | 0393-6384 | |
dc.identifier.issn | 2283-9720 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 793 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/10473 | |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | WOS:000344634300007 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Carbone Editore | en_US |
dc.relation.ispartof | Acta Medica Mediterranea | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hepatitis B virus infection | en_US |
dc.subject | Immunity | en_US |
dc.subject | Inactive carrier | en_US |
dc.subject | Vitamin D | en_US |
dc.title | INVESTIGATION OF VITAMIN D LEVELS IN PATIENTS WITH INACTIVE HEPATITIS B VIRUS CARRIER | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1